Angiotensin II, III, and IV May Be Important in the Progression of COVID-19

Overview

Journal J Renin Angiotensin Aldosterone Syst

Publisher Sage Publications

Specialty Physiology

Date 2020 Nov 10

PMID 33169633

Citations 5

Authors

Erkan Cure

Tevfik Bulent Ilcol

Medine Cumhur Cure

Affiliations

Soon will be listed here.

Citing Articles

The relationship between chronic immune response and neurodegenerative damage in long COVID-19.

Elizalde-Diaz J, Miranda-Narvaez C, Martinez-Lazcano J, Martinez-Martinez E Front Immunol. 2023; 13:1039427.

PMID: 36591299 PMC: 9800881. DOI: 10.3389/fimmu.2022.1039427.

Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.

Chen Y, Huang D, Yuan W, Chang J, Yuan Z, Wu D Infect Dis Ther. 2021; 10(4):2431-2446.

PMID: 34387835 PMC: 8361819. DOI: 10.1007/s40121-021-00513-8.

Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.

Cooper S, Boyle E, Jefferson S, Heslop C, Mohan P, Mohanraj G Int J Mol Sci. 2021; 22(15).

PMID: 34361021 PMC: 8347967. DOI: 10.3390/ijms22158255.

Effects of the Na/H Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease.

Cumhur Cure M, Cure E J Renin Angiotensin Aldosterone Syst. 2021; 2021:4754440.

PMID: 34285709 PMC: 8265032. DOI: 10.1155/2021/4754440.

Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

Cook J, Ausiello J Rev Endocr Metab Disord. 2021; 23(2):151-170.

PMID: 34195965 PMC: 8245275. DOI: 10.1007/s11154-021-09663-z.

References

Ahmad S, Varagic J, Groban L, DellItalia L, Nagata S, Kon N . Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. Curr Hypertens Rep. 2014; 16(5):429. PMC: 4007169. DOI: 10.1007/s11906-014-0429-9. View

McKinney C, Fattah C, Loughrey C, Milligan G, Nicklin S . Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. Clin Sci (Lond). 2014; 126(12):815-27. DOI: 10.1042/CS20130436. View

Alhenc-Gelas F, Drueke T . Blockade of SARS-CoV-2 infection by recombinant soluble ACE2. Kidney Int. 2020; 97(6):1091-1093. PMC: 7194930. DOI: 10.1016/j.kint.2020.04.009. View

Cure E, Cumhur Cure M . Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'. J Hypertens. 2020; 38(6):1189-1198. PMC: 7236845. DOI: 10.1097/HJH.0000000000002481. View

Gerotziafas G, Catalano M, Colgan M, Pecsvarady Z, Wautrecht J, Fazeli B . Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost. 2020; 120(12):1597-1628. PMC: 7869052. DOI: 10.1055/s-0040-1715798. View

Mustafa T, Lee J, Chai S, Albiston A, McDowall S, Mendelsohn F . Bioactive angiotensin peptides: focus on angiotensin IV. J Renin Angiotensin Aldosterone Syst. 2002; 2(4):205-10. DOI: 10.3317/jraas.2001.032. View

Roszkowska-Chojecka M, Walkowska A, Gawrys O, Baranowska I, Kalisz M, Litwiniuk A . Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat. Exp Physiol. 2015; 100(9):1093-105. DOI: 10.1113/EP085325. View

Senchenkova E, Russell J, Kurmaeva E, Ostanin D, Granger D . Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension. 2011; 58(5):959-65. PMC: 3199307. DOI: 10.1161/HYPERTENSIONAHA.111.173856. View

Schindler C, Bramlage P, Kirch W, Ferrario C . Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag. 2007; 3(1):125-37. PMC: 1994039. View

10.

Miura S, Karnik S, Saku K . Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects. J Renin Angiotensin Aldosterone Syst. 2010; 12(1):1-7. PMC: 3891529. DOI: 10.1177/1470320310370852. View

11.

Pirola C, Sookoian S . Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis. J Infect. 2020; 81(2):276-281. PMC: 7255761. DOI: 10.1016/j.jinf.2020.05.052. View

12.

Numaguchi Y, Ishii M, Kubota R, Morita Y, Yamamoto K, Matsushita T . Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis. Arterioscler Thromb Vasc Biol. 2009; 29(12):2102-8. DOI: 10.1161/ATVBAHA.109.195057. View

13.

Chappell M . Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?. Am J Physiol Heart Circ Physiol. 2015; 310(2):H137-52. PMC: 4796631. DOI: 10.1152/ajpheart.00618.2015. View

14.

Hrenak J, Paulis L, Simko F . Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology. Int J Mol Sci. 2016; 17(7). PMC: 4964474. DOI: 10.3390/ijms17071098. View

15.

Senchenkova E, Russell J, Almeida-Paula L, Harding J, Granger D . Angiotensin II-mediated microvascular thrombosis. Hypertension. 2010; 56(6):1089-95. PMC: 3023299. DOI: 10.1161/HYPERTENSIONAHA.110.158220. View

16.

Wright J, Krebs L, Stobb J, Harding J . The angiotensin IV system: functional implications. Front Neuroendocrinol. 1995; 16(1):23-52. DOI: 10.1006/frne.1995.1002. View

17.

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

18.

Zhang F, Liu J, Li S, Song J, Ren J, Chen H . Angiotensin-(1-7): new perspectives in atherosclerosis treatment. J Geriatr Cardiol. 2016; 12(6):676-82. PMC: 4712375. DOI: 10.11909/j.issn.1671-5411.2015.06.014. View

19.

Pang X, Cui Y, Zhu Y . Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication. Acta Pharmacol Sin. 2020; 41(9):1255-1257. PMC: 7313652. DOI: 10.1038/s41401-020-0430-6. View

20.

Ilcol T, Cure E, Cumhur Cure M . Comment on "ACE inhibitors and COVID-19: We don't know yet". J Card Surg. 2020; 35(6):1387. PMC: 7307017. DOI: 10.1111/jocs.14647. View